Director Janet Lee Meiklejohn filed a Form 4 with the SEC on October 30, 2026, disclosing the grant of 100,000 stock options in Jaguar Uranium Corp. on October 29, 2026.

Key Highlights

  • Grant date: 100,000 stock options were granted to director Janet Lee Meiklejohn on October 29, 2026.
  • Exercise price: The filing lists the price of the derivative security as $0, with each option representing the right to purchase one Class A Common Share at a conversion or exercise price of $1.
  • Vesting schedule: One-third vested immediately on October 29, 2026; one-third vests on April 29, 2027; and one-third vests on October 29, 2027, subject to continued service as a director through each vesting date.
  • Expiration: The stock options expire five years after the relevant vesting date, according to the filing.
  • Plan: The options were granted under Jaguar Uranium Corp.'s 2025 Equity Incentive Plan, as amended.
  • Post-transaction ownership: Meiklejohn beneficially owns 100,000 derivative securities following the reported transaction, held directly.

Details of the Option Grant to Director Meiklejohn

According to the Form 4 filed on October 30, 2026, Janet Lee Meiklejohn, a director of Jaguar Uranium Corp. (NASDAQ:JAGU), received a grant of 100,000 stock options on October 29, 2026. The filing states that each option represents the right to purchase one Class A Common Share under the issuer's 2025 Equity Incentive Plan, as amended. The exercise price of the derivative security is listed as $1 per share.

The filing discloses a three-tranche vesting structure. One-third of the options vested immediately upon grant on October 29, 2026. The second tranche is scheduled to vest on April 29, 2027, and the remaining third on October 29, 2027. The filing specifies that vesting of each tranche is "subject to the Reporting Person's continued service as a director through each vesting date." The options expire five years after the relevant vesting date, per the filing's explanation of responses.

The Form 4 was signed by William Avery as attorney-in-fact for Janet Lee Meiklejohn and submitted on October 30, 2026. Following the reported transaction, Meiklejohn's beneficial ownership of derivative securities stands at 100,000 stock options, held directly, as disclosed in the filing. No non-derivative securities transactions were reported in Table I.

What Was Disclosed

The filing reported the acquisition of 100,000 stock options by director Janet Lee Meiklejohn in Jaguar Uranium Corp. on October 29, 2026, under the company's 2025 Equity Incentive Plan, as amended, with a three-part vesting schedule and a $1 exercise price per share.